Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 13, 2007
The use of FoxP3 as a biomarker and prognostic factor for malignant human tumorsTaylor H SchreiberImmunologic Research|November 19, 2013
Immunobiology of TNFSF15 and TNFRSF25Taylor H Schreiber, Eckhard R PodackFrontiers in Immunology|October 5, 2023
Reconciling intrinsic properties of activating TNF receptors by native ligands versus synthetic agonistsGeorge Fromm, Suresh de Silva, Taylor H SchreiberOncoimmunology|August 31, 2012
Tumor antigen specific iTreg accumulate in the tumor microenvironment and suppress therapeutic vaccinationTaylor H Schreiber, Dietlinde Wolf, Maria Bodero, et al.Seminars in Immunology|March 16, 2010
Tumor immunogenicity and responsiveness to cancer vaccine therapy: the state of the artTaylor H Schreiber, Luis Raez, Joseph D Rosenblatt, et al.Immunologic Research|November 21, 2013
Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseasesNatasa Strbo, Arlene Garcia-Soto, Taylor H Schreiber, et al.Cancer Research|February 19, 2009
Tumor-induced suppression of CTL expansion and subjugation by gp96-Ig vaccinationTaylor H Schreiber, Vadim V Deyev, Joseph D Rosenblatt, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 8, 2012
T cell costimulation by TNFR superfamily (TNFRSF)4 and TNFRSF25 in the context of vaccinationTaylor H Schreiber, Dietlinde Wolf, Maria Bodero, et al.Blood|October 14, 2006
Shear flow-dependent integration of apical and subendothelial chemokines in T-cell transmigration: implications for locomotion and the multistep paradigmTaylor H Schreiber, Vera Shinder, Derek W Cain, et al.European Journal of Cancer (Oxford, England : 1990)|May 11, 2023
Shining a LIGHT on myeloid cell targeted immunotherapyCasey W Shuptrine, Vincent M Perez, Sara R Selitsky, et al.Pageof 4